impotence
The patients who developed impotence were maintained on higher doses of sulpiride and exhibited higher prolactin levels in comparison to the potent patients.
The patients who developed <span class="disease" id="4001434-5-27-36">impotence</span> were maintained on higher doses of sulpiride and exhibited higher <span class="gene" id="4001434-5-103-112">prolactin</span> levels in comparison to the potent patients.